As suggested by Heath et al. (2025), the definition of mitochondrial disease must evolve from strictly describing generalized clinical syndromes and phenotypes (like LKENP in AARS2 mutations) and start describing mitochondrial disorders based on the specific gene that is mutated and causing the phenotype. The gene discussed is AARS2; the disease is inborn mitochondrial metabolism disorder.